| Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism (NCT03052075) | M.D. Anderson Cancer Center | 2014-09-03 |
| Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia (NCT02131584) | M.D. Anderson Cancer Center | 2014-09-02 |
| Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma (NCT02114502) | M.D. Anderson Cancer Center | 2014-09-01 |
| Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery (NCT02165995) | M.D. Anderson Cancer Center | 2014-09-01 |
| MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy (NCT02089230) | M.D. Anderson Cancer Center | 2014-08-27 |
| Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors (NCT02239900) | M.D. Anderson Cancer Center | 2014-08-26 |
| Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy (NCT01998529) | M.D. Anderson Cancer Center | 2014-08-20 |
| T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer (NCT02113657) | M.D. Anderson Cancer Center | 2014-08-20 |
| A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms (NCT02163226) | M.D. Anderson Cancer Center | 2014-08-06 |
| Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC) (NCT02060370) | M.D. Anderson Cancer Center | 2014-08-01 |
| A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy (NCT02193672) | M.D. Anderson Cancer Center | 2014-08-01 |
| Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter (NCT01900730) | M.D. Anderson Cancer Center | 2014-07-31 |
| Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients (NCT02152943) | M.D. Anderson Cancer Center | 2014-07-17 |
| Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer (NCT02217865) | M.D. Anderson Cancer Center | 2014-07-16 |
| A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma (NCT02042950) | M.D. Anderson Cancer Center | 2014-07-14 |
| PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing (NCT02282969) | M.D. Anderson Cancer Center | 2014-07-11 |
| Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis (NCT01952847) | M.D. Anderson Cancer Center | 2014-07-10 |
| Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG (NCT01815346) | M.D. Anderson Cancer Center | 2014-07-06 |
| MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies (NCT02042989) | M.D. Anderson Cancer Center | 2014-06-27 |
| Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging (NCT02203136) | M.D. Anderson Cancer Center | 2014-06-25 |
| Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) (NCT01926665) | M.D. Anderson Cancer Center | 2014-06-17 |
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) (NCT01562301) | M.D. Anderson Cancer Center | 2014-06-01 |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) (NCT02044601) | M.D. Anderson Cancer Center | 2014-06-01 |
| Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma (NCT01995669) | M.D. Anderson Cancer Center | 2014-05-27 |
| Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea (NCT01856114) | M.D. Anderson Cancer Center | 2014-05-27 |
| Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) (NCT01994590) | M.D. Anderson Cancer Center | 2014-05-19 |
| Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma (NCT02062749) | M.D. Anderson Cancer Center | 2014-05-19 |
| Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia (NCT02115295) | M.D. Anderson Cancer Center | 2014-05-19 |
| Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01787474) | M.D. Anderson Cancer Center | 2014-05-19 |
| Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer (NCT02107105) | M.D. Anderson Cancer Center | 2014-05-16 |
| Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer (NCT01755130) | M.D. Anderson Cancer Center | 2014-05-13 |
| Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II) (NCT02152254) | M.D. Anderson Cancer Center | 2014-05-13 |
| Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer (NCT02092298) | M.D. Anderson Cancer Center | 2014-05-08 |
| Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer (NCT02055963) | M.D. Anderson Cancer Center | 2014-05-06 |
| Using Social Networks to Promote Physical Activity in African American and Hispanic Women (NCT03199196) | M.D. Anderson Cancer Center | 2014-05-02 |
| Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease (NCT01864070) | M.D. Anderson Cancer Center | 2014-05-01 |
| Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02095834) | M.D. Anderson Cancer Center | 2014-04-24 |
| Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia (NCT01904136) | M.D. Anderson Cancer Center | 2014-04-22 |
| Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT02096055) | M.D. Anderson Cancer Center | 2014-04-04 |
| Phase I/II - Brentuximab/5-Azacytidine in Acute Myeloid Leukemia (AML) (NCT02096042) | M.D. Anderson Cancer Center | 2014-04-01 |
| An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy) (NCT02029612) | M.D. Anderson Cancer Center | 2014-04-01 |
| Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation (NCT01627080) | M.D. Anderson Cancer Center | 2014-04-01 |
| Regorafenib and Cetuximab in Patients With Advanced Malignancy (NCT02095054) | M.D. Anderson Cancer Center | 2014-03-19 |
| Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant (NCT02083250) | M.D. Anderson Cancer Center | 2014-03-06 |
| Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01946152) | M.D. Anderson Cancer Center | 2014-03-05 |
| Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) (NCT02010645) | M.D. Anderson Cancer Center | 2014-03-01 |
| Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM) (NCT02263014) | M.D. Anderson Cancer Center | 2014-02-24 |
| Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT01895842) | M.D. Anderson Cancer Center | 2014-02-01 |
| Physical Activity in Promoting Smoking Cessation in African Americans (NCT01915810) | M.D. Anderson Cancer Center | 2014-01-29 |
| Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer (NCT01471106) | M.D. Anderson Cancer Center | 2014-01-21 |
| Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer (NCT02043158) | M.D. Anderson Cancer Center | 2014-01-16 |
| Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer (NCT01628029) | M.D. Anderson Cancer Center | 2014-01-15 |
| Fentanyl for Breakthrough Pain in the Emergency Department (NCT01812759) | M.D. Anderson Cancer Center | 2014-01-10 |
| Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer (NCT01630590) | M.D. Anderson Cancer Center | 2014-01-08 |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients (NCT02253238) | M.D. Anderson Cancer Center | 2014-01-07 |
| Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis (NCT01807286) | M.D. Anderson Cancer Center | 2014-01-01 |
| Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer (NCT01949662) | M.D. Anderson Cancer Center | 2014-01-01 |
| Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) (NCT01927718) | M.D. Anderson Cancer Center | 2014-01-01 |
| Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (NCT01875237) | M.D. Anderson Cancer Center | 2013-12-27 |
| Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01891981) | M.D. Anderson Cancer Center | 2013-12-17 |
| Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection (NCT01927744) | M.D. Anderson Cancer Center | 2013-12-16 |
| Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT02007044) | M.D. Anderson Cancer Center | 2013-12-06 |
| Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT01985477) | M.D. Anderson Cancer Center | 2013-12-01 |
| Middle and High School Students' Reactions to a Health Interactive Website: ASPIRE Reactions (NCT02469779) | M.D. Anderson Cancer Center | 2013-12-01 |
| BiPAP-Vapotherm RCT (NCT01518140) | M.D. Anderson Cancer Center | 2013-12-01 |
| IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02028039) | M.D. Anderson Cancer Center | 2013-12-01 |
| CASAD for Severe Diarrhea in the Emergency Department (NCT02018653) | M.D. Anderson Cancer Center | 2013-12-01 |
| Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01892371) | M.D. Anderson Cancer Center | 2013-11-12 |
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma (NCT01983969) | M.D. Anderson Cancer Center | 2013-11-07 |
| Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies (NCT01919619) | M.D. Anderson Cancer Center | 2013-11-04 |
| Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients (NCT01906008) | M.D. Anderson Cancer Center | 2013-11-01 |
| Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide (NCT01946165) | M.D. Anderson Cancer Center | 2013-10-31 |
| Effects of Meditation on Cognitive Function and Quality of Life (NCT02162329) | M.D. Anderson Cancer Center | 2013-10-22 |
| Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma (NCT01833520) | M.D. Anderson Cancer Center | 2013-10-16 |
| APPSPIRE App in Preventing Students From Smoking (NCT01967082) | M.D. Anderson Cancer Center | 2013-10-16 |
| Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant (NCT01927731) | M.D. Anderson Cancer Center | 2013-10-14 |
| Hypofractionated Proton Beam Therapy for Localized Prostate Cancer (NCT01950351) | M.D. Anderson Cancer Center | 2013-10-10 |
| A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT01797523) | M.D. Anderson Cancer Center | 2013-10-07 |
| Plerixafor for Stem Cell Mobilization in Normal Donors (NCT01818284) | M.D. Anderson Cancer Center | 2013-10-01 |
| Carfilzomib in Refractory Renal Cell Carcinoma (RCC) (NCT01775930) | M.D. Anderson Cancer Center | 2013-10-01 |
| Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy (NCT01894607) | M.D. Anderson Cancer Center | 2013-10-01 |
| Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) (NCT01893372) | M.D. Anderson Cancer Center | 2013-10-01 |
| Hatha Yoga in Lung Cancer Couples (NCT01952860) | M.D. Anderson Cancer Center | 2013-09-23 |
| A Feasibility Study of Prophylactic White Blood Cell Transfusions (NCT01932710) | M.D. Anderson Cancer Center | 2013-09-20 |
| Text Messages in Preventing Tobacco Use in Young Adults (NCT03457480) | M.D. Anderson Cancer Center | 2013-09-20 |
| Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT01900002) | M.D. Anderson Cancer Center | 2013-09-13 |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI (NCT01895829) | M.D. Anderson Cancer Center | 2013-09-12 |
| Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX) (NCT01902966) | M.D. Anderson Cancer Center | 2013-09-11 |
| Circulating Tumor Cells in Patients With Locally Advanced Rectal Cancer (NCT02874885) | M.D. Anderson Cancer Center | 2013-09-05 |
| Open-Label Study of TPI 287 for Patients With Metastatic Melanoma (NCT01340729) | M.D. Anderson Cancer Center | 2013-09-01 |
| Intravesical Cidofovir for Hemorrhagic Cystitis (NCT01816646) | M.D. Anderson Cancer Center | 2013-09-01 |
| Prophylactic Salpingectomy With Delayed Oophorectomy (NCT01907789) | M.D. Anderson Cancer Center | 2013-08-26 |
| Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer (NCT01893307) | M.D. Anderson Cancer Center | 2013-08-26 |
| Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation (NCT01891968) | M.D. Anderson Cancer Center | 2013-08-07 |
| Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors (NCT01751425) | M.D. Anderson Cancer Center | 2013-07-24 |
| Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome (NCT01893320) | M.D. Anderson Cancer Center | 2013-07-18 |
| Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor (NCT01603212) | M.D. Anderson Cancer Center | 2013-07-18 |
| Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers (NCT01811628) | M.D. Anderson Cancer Center | 2013-07-17 |
| Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei (NCT01946854) | M.D. Anderson Cancer Center | 2013-07-16 |
| Ibrutinib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Older Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT01880567) | M.D. Anderson Cancer Center | 2013-07-15 |